Abiopharma

Inotiv Reaches Agreement to Strengthen Capital Structure and Position Company for Future Growth

Trustee report to the holders of Series 11 - Hermetic Trust (1975) Ltd.

Trustee report to the holders of Series 9 - Hermetic Trust (1975) Ltd.

Mineralys Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock

OwlTing Group (NASDAQ: OWLS) Secures Ohio Money Transmitter License, Extending U.S. Coverage to 42 States

MannKind Enters Data-Rich Development Period with Completion of Randomization in Phase 1b INFLO-1 Study and Enrollment of First Patient in Phase 2 INFLO-2 Trial for Nintedanib DPI in Patients with IPF

Mineralys Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock

Update regarding Hadera power station project expansion and exercise of the option to extend the lease agreement on the land owned by the subsidiary (in chain) Infinia

IDEAYA Biosciences Announces Clinical Collaboration with Roche in MTAP-Deleted RAS-Mutant Pancreatic Cancer

Register of shareholders, changes and capital status – issuance of deferred debentures (Series 6)